|
1
|
Kapranov P, Willingham AT and Gingeras TR:
Genome-wide transcription and the implications for genomic
organization. Nat Rev Genet. 8:413–423. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lau E: Non-coding RNA: Zooming in on
lncRNA functions. Nat Rev Genet. 15:574–575. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ponjavic J, Ponting CP and Lunter G:
Functionality or transcriptional noise? Evidence for selection
within long noncoding RNAs. Genome Res. 17:556–565. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang G, Lu X and Yuan L: LncRNA: A link
between RNA and cancer. Biochim Biophys Acta. 1839:1097–1109. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang L, Yang F, Yuan JH, Yuan SX, Zhou
WP, Huo XS, Xu D, Bi HS, Wang F and Sun SH: Epigenetic activation
of the MiR-200 family contributes to H19-mediated metastasis
suppression in hepatocellular carcinoma. Carcinogenesis.
34:577–586. 2013. View Article : Google Scholar
|
|
7
|
Huang JF, Guo YJ, Zhao CX, Yuan SX, Wang
Y, Tang GN, Zhou WP and Sun SH: Hepatitis B virus X protein
(HBx)-related long noncoding RNA (lncRNA) down-regulated expression
by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by
targeting the intermediate filament protein vimentin. Hepatology.
57:1882–1892. 2013. View Article : Google Scholar
|
|
8
|
Du Y, Kong G, You X, Zhang S, Zhang T, Gao
Y, Ye L and Zhang X: Elevation of highly up-regulated in liver
cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell
proliferation via down-regulating p18. J Biol Chem.
287:26302–26311. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang Z, Zhou L, Wu LM, Lai MC, Xie HY,
Zhang F and Zheng SS: Overexpression of long non-coding RNA HOTAIR
predicts tumor recurrence in hepatocellular carcinoma patients
following liver transplantation. Ann Surg Oncol. 18:1243–1250.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Takahashi K, Yan I, Haga H and Patel T:
Long noncoding RNA in liver diseases. Hepatology. 60:744–753. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mohamadkhani A: Long Noncoding RNAs in
interaction with RNA binding proteins in hepatocellular carcinoma.
Hepat Mon. 14:e187942014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ji Q, Zhang L, Liu X, Zhou L, Wang W, Han
Z, Sui H, Tang Y, Wang Y, Liu N, et al: Long non-coding RNA MALAT1
promotes tumour growth and metastasis in colorectal cancer through
binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2
complex. Br J Cancer. 111:736–748. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dong Y, Liang G, Yuan B, Yang C, Gao R and
Zhou X: MALAT1 promotes the proliferation and metastasis of
osteosarcoma cells by activating the PI3K/Akt pathway. Tumour Biol.
36:1477–1486. 2015. View Article : Google Scholar
|
|
14
|
Tripathi V, Ellis JD, Shen Z, Song DY, Pan
Q, Watt AT, Freier SM, Bennett CF, Sharma A, Bubulya PA, et al: The
nuclear-retained noncoding RNA MALAT1 regulates alternative
splicing by modulating SR splicing factor phosphorylation. Mol
Cell. 39:925–938. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY,
Zhang F, Wu LM, Chen LM and Zheng SS: Long non-coding RNA MALAT-1
over-expression predicts tumor recurrence of hepatocellular
carcinoma after liver transplantation. Med Oncol. 29:1810–1816.
2012. View Article : Google Scholar
|
|
16
|
Yang JH, Li JH, Jiang S, Zhou H and Qu LH:
ChIPBase: A database for decoding the transcriptional regulation of
long non-coding RNA and microRNA genes from ChIP-Seq data. Nucleic
Acids Res. 41(D1): D177–D187. 2013. View Article : Google Scholar :
|
|
17
|
Wu Z, Liu X, Liu L, Deng H, Zhang J, Xu Q,
Cen B and Ji A: Regulation of lncRNA expression. Cell Mol Biol
Lett. 19:561–575. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Uesaka M, Nishimura O, Go Y, Nakashima K,
Agata K and Imamura T: Bidirectional promoters are the major source
of gene activation-associated non-coding RNAs in mammals. BMC
Genomics. 15:352014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Alam T, Medvedeva YA, Jia H, Brown JB,
Lipovich L and Bajic VB: Promoter analysis reveals globally
differential regulation of human long non-coding RNA and
protein-coding genes. PLoS One. 9:e1094432014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen G, Kronenberger P, Teugels E, Umelo
IA and De Grève J: Targeting the epidermal growth factor receptor
in non-small cell lung cancer cells: The effect of combining RNA
interference with tyrosine kinase inhibitors or cetuximab. BMC Med.
10:282012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yuan P, Wang L, Wei D, Zhang J, Jia Z, Li
Q, Le X, Wang H, Yao J and Xie K: Therapeutic inhibition of Sp1
expression in growing tumors by mithramycin a correlates directly
with potent antiangiogenic effects on human pancreatic cancer.
Cancer. 110:2682–2690. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Narayan VA, Kriwacki RW and Caradonna JP:
Structures of zinc finger domains from transcription factor Sp1.
Insights into sequence-specific protein-DNA recognition. J Biol
Chem. 272:7801–7809. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li L and Davie JR: The role of Sp1 and Sp3
in normal and cancer cell biology. Ann Anat. 192:275–283. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ren S, Wang F, Shen J, Sun Y, Xu W, Lu J,
Wei M, Xu C, Wu C, Zhang Z, et al: Long non-coding RNA metastasis
associated in lung adenocarcinoma transcript 1 derived miniRNA as a
novel plasma-based biomarker for diagnosing prostate cancer. Eur J
Cancer. 49:2949–2959. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gutschner T, Hämmerle M, Eissmann M, Hsu
J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, et al:
The noncoding RNA MALAT1 is a critical regulator of the metastasis
phenotype of lung cancer cells. Cancer Res. 73:1180–1189. 2013.
View Article : Google Scholar :
|
|
26
|
Gutschner T, Hämmerle M and Diederichs S:
MALAT1 - a paradigm for long noncoding RNA function in cancer. J
Mol Med Berl. 91:791–801. 2013. View Article : Google Scholar
|
|
27
|
Ji P, Diederichs S, Wang W, Böing S,
Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et
al: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict
metastasis and survival in early-stage non-small cell lung cancer.
Oncogene. 22:8031–8041. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hutchinson JN, Ensminger AW, Clemson CM,
Lynch CR, Lawrence JB and Chess A: A screen for nuclear transcripts
identifies two linked noncoding RNAs associated with SC35 splicing
domains. BMC Genomics. 8:392007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang J, Wang H, Zhang Y, Zhen N, Zhang L,
Qiao Y, Weng W, Liu X, Ma L, Xiao W, et al: Mutual inhibition
between YAP and SRSF1 maintains long non-coding RNA, Malat1-induced
tumourigenesis in liver cancer. Cell Signal. 26:1048–1059. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tano K, Mizuno R, Okada T, Rakwal R,
Shibato J, Masuo Y, Ijiri K and Akimitsu N: MALAT-1 enhances cell
motility of lung adenocarcinoma cells by influencing the expression
of motility-related genes. FEBS Lett. 584:4575–4580. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li B, Chen P, Qu J, Shi L and Zhuang W, Fu
J, Li J, Zhang X, Sun Y and Zhuang W: Activation of LTBP3 gene by a
long noncoding RNA (lncRNA) MALAT1 transcript in mesenchymal stem
cells from multiple myeloma. J Biol Chem. 289:29365–29375. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bonasio R and Shiekhattar R: Regulation of
transcription by long noncoding RNAs. Annu Rev Genet. 48:433–455.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Beishline K and Azizkhan-Clifford J: Sp1
and the 'hallmarks of cancer'. FEBS J. 282:224–258. 2015.
View Article : Google Scholar
|
|
34
|
Sankpal UT, Maliakal P, Bose D, Kayaleh O,
Buchholz D and Basha R: Expression of specificity protein
transcription factors in pancreatic cancer and their association in
prognosis and therapy. Curr Med Chem. 19:3779–3786. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tong Y, Tan Y, Zhou C and Melmed S:
Pituitary tumor transforming gene interacts with Sp1 to modulate
G1/S cell phase transition. Oncogene. 26:5596–5605. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jiang NY, Woda BA, Banner BF, Whalen GF,
Dresser KA and Lu D: Sp1, a new biomarker that identifies a subset
of aggressive pancreatic ductal adenocarcinoma. Cancer Epidemiol
Biomarkers Prev. 17:1648–1652. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Galvagni F, Capo S and Oliviero S: Sp1 and
Sp3 physically interact and co-operate with GABP for the activation
of the utrophin promoter. J Mol Biol. 306:985–996. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li S, Wang Q, Qiang Q, Shan H, Shi M, Chen
B, Zhao S and Yuan L: Sp1-mediated transcriptional regulation of
MALAT1 plays a critical role in tumor. J Cancer Res Clin Oncol.
16–March;2015.(Epub ahead of print). View Article : Google Scholar
|
|
39
|
Mir MA, Majee S, Das S and Dasgupta D:
Association of chromatin with anticancer antibiotics, mithramycin
and chromomycin A3. Bioorg Med Chem. 11:2791–2801. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Choi ES, Nam JS, Jung JY, Cho NP and Cho
SD: Modulation of specificity protein 1 by mithramycin A as a novel
therapeutic strategy for cervical cancer. Sci Rep. 4:71622014.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Osada N, Kosuge Y, Ishige K and Ito Y:
Mithramycin, an agent for developing new therapeutic drugs for
neurodegenerative diseases. J Pharmacol Sci. 122:251–256. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kajita Y, Kato T Jr, Tamaki S, Furu M,
Takahashi R, Nagayama S, Aoyama T, Nishiyama H, Nakamura E,
Katagiri T, et al: The transcription factor Sp3 regulates the
expression of a metastasis-related marker of sarcoma, actin
filament-associated protein 1-like 1 (AFAP1L1). PLoS One.
8:e497092013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Huong PT, Soung NK, Jang JH, Cha-Molstad
HJ, Sakchaisri K, Kim SO, Jang JM, Kim KE, Lee KS, Kwon YT, et al:
Regulation of CEP131 gene expression by SP1. Gene. 513:75–81. 2013.
View Article : Google Scholar
|
|
44
|
Zhang M, Mathur A, Zhang Y, Xi S, Atay S,
Hong JA, Datrice N, Upham T, Kemp CD, Ripley RT, et al: Mithramycin
represses basal and cigarette smoke-induced expression of ABCG2 and
inhibits stem cell signaling in lung and esophageal cancer cells.
Cancer Res. 72:4178–4192. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hsu TI, Wang MC, Chen SY, Huang ST, Yeh
YM, Su WC, Chang WC and Hung JJ: Betulinic acid decreases
specificity protein 1 (Sp1) level via increasing the sumoylation of
sp1 to inhibit lung cancer growth. Mol Pharmacol. 82:1115–1128.
2012. View Article : Google Scholar : PubMed/NCBI
|
